SHELTON DAVID LOUIS
No ORCID on file
· 75 papers in corpus
2010
The present invention relates to the use of an NGF antagonist in the treatment or prevention of endometriosis and/or uterine fibroids.
2010
The present invention relates to the use of an NGF antagonist in the treatment or prevention of endometriosis and/or uterine fibroids.
2010
The present invention relates to the use of an NGF antagonist in the treatment or prevention of endometriosis and/or uterine fibroids.
2010
The present invention relates to the use of an NGF antagonist in the treatment or prevention of endometriosis and/or uterine fibroids.
2010
The present invention relates to the use of an NGF antagonist in the treatment or prevention of endometriosis and/or uterine fibroids.
2010
The present invention relates to the use of an NGF antagonist in the treatment or prevention of endometriosis and/or uterine fibroids.
2010
The present invention relates to the use of an NGF antagonist in the treatment or prevention of endometriosis and/or uterine fibroids.
2010
The present invention relates to the use of an NGF antagonist in the treatment or prevention of endometriosis and/or uterine fibroids.
2010
The present invention relates to the use of an NGF antagonist in the treatment or prevention of endometriosis and/or uterine fibroids.
2010
The present invention relates to the use of an NGF antagonist in the treatment or prevention of endometriosis and/or uterine fibroids.
2010
The present invention relates to the use of an NGF antagonist in the treatment or prevention of endometriosis and/or uterine fibroids.
2010
The present invention relates to the use of an NGF antagonist in the treatment or prevention of endometriosis and/or uterine fibroids.
2010
The present invention relates to the use of an NGF antagonist in the treatment or prevention of endometriosis and/or uterine fibroids.
2010
The present invention relates to the use of an NGF antagonist in the treatment or prevention of endometriosis and/or uterine fibroids.
2010
The present invention relates to the use of an NGF antagonist in the treatment or prevention of endometriosis and/or uterine fibroids.
2010
The present invention relates to the use of an NGF antagonist in the treatment or prevention of endometriosis and/or uterine fibroids.
2010
The present invention relates to the use of an NGF antagonist in the treatment or prevention of endometriosis and/or uterine fibroids.
2010
The present invention relates to the use of an NGF antagonist in the treatment or prevention of endometriosis and/or uterine fibroids.
2010
The present invention relates to the use of an NGF antagonist in the treatment or prevention of endometriosis and/or uterine fibroids.
2010
The present invention relates to the use of an NGF antagonist in the treatment or prevention of endometriosis and/or uterine fibroids.
2010
The present invention relates to the use of an NGF antagonist in the treatment or prevention of endometriosis and/or uterine fibroids.
2010
The present invention relates to the use of an NGF antagonist in the treatment or prevention of endometriosis and/or uterine fibroids.
2010
The present invention relates to the use of an NGF antagonist in the treatment or prevention of endometriosis and/or uterine fibroids.
2010
The present invention relates to the use of an NGF antagonist in the treatment or prevention of endometriosis and/or uterine fibroids.
2010
The present invention relates to the use of an NGF antagonist in the treatment or prevention of endometriosis and/or uterine fibroids.